2012
DOI: 10.1007/s10067-012-2030-4
|View full text |Cite
|
Sign up to set email alerts
|

The promising role of lung ultrasound in systemic sclerosis

Abstract: Ultrasound (US) has an emergent and relevant role in the assessment of systemic sclerosis (SSc) even if there are many fields and applications that still have not been sufficiently explored. In this review, we will report an update of the available data regarding the use of US in lung involvement that might cause disability and mortality in SSc patients. Lung US does not employ ionizing radiation and is more rapid and less expensive than traditional high-resolution tomography (HRCT). Furthermore, recent initia… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
37
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(39 citation statements)
references
References 34 publications
2
37
0
Order By: Relevance
“…Finally, no data are available on large normal populations to confirm the cut-off points and PPV and NPV for this technique in SSc, RA, and other CTDs [ 47 50 ].…”
Section: Limitationsmentioning
confidence: 99%
“…Finally, no data are available on large normal populations to confirm the cut-off points and PPV and NPV for this technique in SSc, RA, and other CTDs [ 47 50 ].…”
Section: Limitationsmentioning
confidence: 99%
“…Various scanning techniques were proposed to reduce the dose (Mayo 2009). Intercostal ultrasound can be used to avoid ionizing radiations during follow-ups (Delle Sedie, et al 2012). However, it is not able to quantify the stiffness of lung.…”
Section: Introductionmentioning
confidence: 99%
“…Lung ultrasound is inexpensive, widely available, reproducible and easily performed at the bedside, in combination with echocardiography [31,32]. When examined against lung HRCT, lung ultrasound has a high sensitivity and negative predictive value for ILD [31,32,33], but it has yet to be validated in the monitoring of ILD progression and has no routine clinical role in the outpatient clinic.…”
Section: Imaging In Monitoringmentioning
confidence: 99%